发明名称 AMANTADINE COMPOSITIONS AND METHODS OF USE
摘要 Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
申请公布号 US2016256414(A1) 申请公布日期 2016.09.08
申请号 US201514857509 申请日期 2015.09.17
申请人 Adamas Pharmaceuticals, Inc. 发明人 Went Gregory T.;Sathyan Gayatri;Vermani Kavita;Ganapati Gangadhara;Coffee Michael;Shek Efraim;Katdare Ashok
分类号 A61K31/13 主分类号 A61K31/13
代理机构 代理人
主权项 1. A pharmaceutical composition consisting of (i) 110 mg to 445 mg of a drug selected from the group consisting of amantadine and pharmaceutically acceptable salts thereof and (ii) at least one excipient, wherein said composition is suitable for once daily, oral administration to a human subject at a time such that the drug does not interfere with sleep, wherein at least one of said excipients modifies the release of the drug to provide an extended release form, and wherein administration of the composition provides a Tmax of 6 to 18 hours as measured in a single dose human pharmacokinetic study and once daily administration provides a C-ave-8-12 hrs to C-ave-0-8 hrs ratio of 1.1 to 2.0 as determined in a multiple dose human pharmacokinetic study.
地址 Emeryville CA US